Last updated: May 28, 2021
Sponsor: Renmin Hospital of Wuhan University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Colon Cancer Screening
Gastrointestinal Diseases And Disorders
Ulcers
Treatment
N/AClinical Study ID
NCT04912037
EA-21-005
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female ≥50 years old;
- Able to read, understand and sign informed consent
- The investigator believes that the subjects can understand the process of the clinicalstudy, are willing and able to complete all study procedures and follow-up visits, andcooperate with the study procedures
- Patients requiring colonoscopy
Exclusion
Exclusion Criteria:
- Have drug or alcohol abuse or mental disorder in the last 5 years
- Pregnant or lactating women
- Patients with known multiple polyp syndrome;
- patients with known inflammatory bowel disease;
- known intestinal stenosis or space-occupying tumor;
- known colon obstruction or perforation;
- patients with a history of colorectal surgery;
- Patients with previous history of allergy to pre-used spasmolysis;
- Unable to perform biopsy and polyp removal due to coagulation disorders or oralanticoagulants;
- High risk diseases or other special conditions that the investigator considers thesubject unsuitable for participation in the clinical trial.
Study Design
Total Participants: 385
Study Start date:
June 01, 2021
Estimated Completion Date:
February 01, 2022
Study Description
Connect with a study center
Renmin hospital of Wuhan University
Wuhan, Hubei 430000
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.